/Companies

Ribonova

Wynnewood, US · 2 known investors

Find your way into Ribonova

Sign up to see every warm intro you have to Ribonova

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ribonova team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RiboNova is a biopharmaceutical company developing small molecule drugs and precision medicines targeting transfer RNA for the treatment of mitochondrial disease. The company operates a proprietary drug discovery platform with a Phase-2 ready candidate in its pipeline.

Investors · 2

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$299.4K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$973.1K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2016$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2015$177.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ribonova do?
RiboNova is a biopharmaceutical company developing small molecule drugs and precision medicines targeting transfer RNA for the treatment of mitochondrial disease. The company operates a proprietary drug discovery platform with a Phase-2 ready candidate in its pipeline.
Who are Ribonova's investors?
Ribonova's investors include BioAdvance, Militia Hill Ventures.
Where is Ribonova headquartered?
Ribonova is headquartered in Wynnewood, US.